Value Based Care in India Measuring Hospital Outcomes



Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) und Allianz Group together with Curo-Health are implementing Vaulue Based Care in India. 

We are measuring hospital outcomes produced and make results available to Patients. Hence enable Patients to take health in their onw hands, have eye level conversations with physicians and access to second opinions and hence become less dependent on shady referrals which can drive health care cost significantly.

Additionally patients are able to pay health care bills via their eWallet and benefit from discounts and have access to emergency loans and doctor on call services. 

Hospitals enter with Value Based Care a path of continuous improvement, have access to quality circles and scientific collaborations, expand their catchment area, build confidence towards customers, retain talents and connect to patients post discharge. VBC has demonstrated to increase quality of care while reducing operating costs. This leads to a competitive advantage in the market place. 

Value Based Care has the potential to redefine healthcare delivery in India: by empowering patients to take health in their own hands and enable hospitals to constantly improve quality produced. 

Manage Depression with University Hospital Zurich, Switzerland


Collaboration with University Hospital Zurich is aiming to improve management of  multi morbid patients with ancillary depression and to develop targeted, personalized therapies. We support USZ to analyze outcomes produced in their clinical practice and derive new insights to better manage complex patients with multi morbid conditions. 

“Advanced clinical analytics can open ways for us to offer personalized and effective medicine to our patients that is evidence based, and may reduce health care costs and improve quality of life of patients,” says Professor Eduoard Battegay, head of Department of Internal Medicine at University Hospital of Zurich.

Read the full article in press release below...

Rapid on-site cytology device development for National Health Service, UK


Development of a device to assess cytology samples through artificial intelligence, for rapid on site cytology results. This device could increase diagnostic yield of bronchoscopy, reduce lung cancer diagnosis time and avoid repeated invasive procedures.

Bronchoscopy is a common technique used to obtain tissue diagnosis of lung cancer, which is crucial to plan further treatment. The results are available after 5-7 days when the pathologists have processed the sample. If the results are inadequate then the clinician must repeat bronchoscopy or other invasive tests are performed which delays the time-to-treatment. Training of a medical doctor in assessing pathological samples is a limiting factor for widespread and routine use of this technique. Hence an automated process using AI allows to assess the samples during the bronchoscopy process.

The Future of Healthcare in Greece Next steps after Bailout


Greece successfully ended the EU bailout program and is now defining its investment priorities without the restrictions from past years. 

Greece Minister of Health Mr. Andreas Xanthos emphasized the focus on quality healthcare and strengthened primary care units. Digital technology and data is core to manage costs and improve health outcomes. Elias Mossialos from London School of Economics LSE described potential reforms / proposals to bend the Curve on Healthcare Costs.

With its rich health data sets of a single payer system, Greece is well positioned to leverage the power of advanced analytics and AI. Mr Tagaris President & Managing Director of IDIKA Greece's e-Government Center for Social Security highlighted a number of projects and Stefan Suter, CEO of Curo-Health complemented how AI and advanced analytics can support such projects. Watch the sessions here:

We are looking forward to future cooperation to support Greek Healthcare system in taking a next leap forward. 

Visit out Partner